ArticleAmerican journal of cancer research2024

Targeted multimodal synergistic therapy of drug-resistant HER2-positive breast cancer by pyrotinib-ICG self-assembled nanoparticles.

Juncheng Xuhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.